Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07115121) titled 'Comparison of Ferric Carboxymaltose and IV Iron Sucrose' on Aug. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Muhammad Aamir Latif

Condition: Anemia

Intervention: Drug: Intravenous Ferric Carboxymaltose

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: February 2, 2025

Target Sample Size: 40

Countries of Recruitment: Pakistan

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07115121

Published by HT Digital Content Services with permis...